Financhill
Back

AbCellera Biologics Stock Predictions

AbCellera Biologics Stock Forecast

  • Is AbCellera Biologics Stock Undervalued?
    The current AbCellera Biologics [ABCL] share price is $3.88. The Score for ABCL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ABCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will AbCellera Biologics Stock Go Up Next Year?

Data Unavailable

AbCellera Biologics Stock Rating

Data Unavailable

AbCellera Biologics Stock Price History

Is ABCL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Canada
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
abcellera.com

52-Week Data

52-Week High:
8.05
52-Week Low:
3.79

Prediction Charts

Market Cap:
1.13B
Price in USD:
3.88
Volume:
921.63K
Beta:
0.37

Technical Analysis

SMA50:
4.71
SMA100:
4.99
SMA200:
5.19
52-Wk Change:
-46.26%

Stock Predictions

  • Is AbCellera Biologics stock public?
    Yes, AbCellera Biologics is a publicly traded company.
  • What is the AbCellera Biologics stock quote today?
    The AbCellera Biologics stock price is 3.88 USD today.
  • How to buy AbCellera Biologics stock online?
    You can buy AbCellera Biologics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-2 4.44 4.32 4.44 4.27
Apr-3 4.30 4.38 4.44 4.25
Apr-4 4.41 4.39 4.57 4.38
Apr-5 4.36 4.34 4.45 4.26
Apr-8 4.38 4.49 4.54 4.35
Apr-9 4.51 4.73 4.75 4.47
Apr-10 4.53 4.46 4.65 4.38
Apr-11 4.50 4.38 4.56 4.33
Apr-12 4.35 4.34 4.42 4.25
Apr-15 4.34 4.19 4.34 4.15
Apr-16 4.13 4.05 4.15 4.03
Apr-17 4.06 3.93 4.15 3.92
Apr-18 3.95 3.91 3.97 3.84
Apr-19 3.85 3.88 3.96 3.79

AbCellera Biologics Earnings

Data Unavailable

AbCellera Biologics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.05 per share.

* AbCellera Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.